
Q32 Bio
(NASDAQ) QTTB
Q32 Bio Financials at a Glance
Market Cap
$78.56M
Revenue (TTM)
$53.74M
Net Income (TTM)
$33.24M
EPS (TTM)
$2.66
P/E Ratio
2.02
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$5.08
Volume
3,114
Open
$5.52
Price
$5.08
Volume
3,114
Open
$5.52
Previous Close
$5.37
Daily Range
$5.08 - $5.53
52-Week Range
$1.34 - $8.04
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$5.08
Volume
3,114
Open
$5.52
Previous Close
$5.37
Daily Range
$5.08 - $5.53
52-Week Range
$1.34 - $8.04
QTTB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Q32 Bio
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Jodie P. Morrison
Website
www.q32bio.comHeadquarters
Waltham, MA 02451, US
QTTB Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
40%
Net Income Margin
62%
Return on Equity
157%
Return on Capital
40%
Return on Assets
52%
Earnings Yield
49.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$78.56M
Shares Outstanding
14.63M
Volume
3.11K
Avg. Volume
287.98K
Financials (TTM)
Gross Profit
$53.35M
Operating Income
$16.90M
EBITDA
$17.29M
Operating Cash Flow
$33.54M
Capital Expenditure
$0.00
Free Cash Flow
$33.54M
Cash & ST Invst.
$48.30M
Total Debt
$15.34M
Q32 Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$90.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$78.56M
N/A
Market Cap/Employee
$2.81M
N/A
Employees
28
N/A
Net Income
$7.61M
+31.0%
EBITDA
$7.63M
+28.1%
Quarterly Fundamentals
Net Cash
$39.76M
-14.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$4.75M
-64.8%
Short Term Debt
$6.24M
+17.9%
Return on Assets
52.21%
N/A
Return on Invested Capital
40.39%
N/A
Free Cash Flow
$6.34M
+49.2%
Operating Cash Flow
$6.34M
+49.2%
